mannitol has been researched along with Agnogenic Myeloid Metaplasia in 4 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 4 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Klimova, NF | 1 |
| Canellos, GP; DeVita, VT; Neiman, PE; Young, RC | 1 |
| Engelmann, C; Konrad, H; Nowotny, P; Schulz, K | 1 |
| Sellei, C | 1 |
1 trial(s) available for mannitol and Agnogenic Myeloid Metaplasia
| Article | Year |
|---|---|
Dibromomannitol in the treatment of chronic granulocytic leukemia: a prospective randomized comparison with busulfan.
Topics: Amenorrhea; Bone Marrow Examination; Busulfan; Chromosome Aberrations; Drug Evaluation; Drug Resistance; Female; Humans; Leukemia, Myeloid; Leukocyte Count; Mannitol; Primary Myelofibrosis; Pulmonary Fibrosis; Skin Pigmentation | 1975 |
3 other study(ies) available for mannitol and Agnogenic Myeloid Metaplasia
| Article | Year |
|---|---|
[10-years experience with myelobromol treatment of myelofibrosis].
Topics: Blood Transfusion; Hematopoiesis; Hepatomegaly; Humans; Mannitol; Mitobronitol; Pancytopenia; Polycythemia; Prednisone; Primary Myelofibrosis; Remission, Spontaneous; Splenomegaly; Thrombocytopenia; Thrombocytosis | 1977 |
[Indications for cytostatic treatment of patients with osteomyelosclerosis of osteomyelofibrosis].
Topics: Adult; Aged; Antineoplastic Agents; Azathioprine; Busulfan; Female; Humans; Male; Mannitol; Mercaptopurine; Middle Aged; Osteosclerosis; Primary Myelofibrosis | 1972 |
Treatment of myeloproliferative diseases.
Topics: Busulfan; Humans; Leukemia, Myeloid; Mannitol; Myeloproliferative Disorders; Polycythemia Vera; Primary Myelofibrosis | 1966 |